Matches in Nanopublications for { ?s ?p "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP521509.RADpppjNAX9PCkbCbhNtmQ_z9MwhLFD-So8V3x-WUXWM8130_assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521509.RADpppjNAX9PCkbCbhNtmQ_z9MwhLFD-So8V3x-WUXWM8130_provenance.
- NP521502.RAf1fPKL6tJpmOMoT9gbfOgOfMeWtPVsV4PDbAdusuC3w130_assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521502.RAf1fPKL6tJpmOMoT9gbfOgOfMeWtPVsV4PDbAdusuC3w130_provenance.
- NP521506.RATQtrjEccg_B_64DC1QK9IAGY2qEQaf7-8eP1Ue3pLlI130_assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521506.RATQtrjEccg_B_64DC1QK9IAGY2qEQaf7-8eP1Ue3pLlI130_provenance.
- assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP521507.RAINx0FDOoPGWmM9QQCSi_sYg9knJF-oUYckQbtxgFf0s130_assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521507.RAINx0FDOoPGWmM9QQCSi_sYg9knJF-oUYckQbtxgFf0s130_provenance.
- NP665542.RAl1HAQlyrTEgxQoMBcih65U7FqdFUnBMOaz-wYuub-U0130_assertion description "[It was thought that the fusion protein PML-RARalpha acts as a double dominant negative mutant to inhibit the PML and RARalpha signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665542.RAl1HAQlyrTEgxQoMBcih65U7FqdFUnBMOaz-wYuub-U0130_provenance.